News | February 14, 2008

Merge Healthcare Announces Rightsizing Initiative

February 15, 2008 - Merge Technologies Inc. announced a rightsizing initiative and the planned timing of the issuance of its third quarter 2007 financial results and business operations and strategy conference call.

The details of the rightsizing include:

- Total worldwide headcount at Sept. 30, 2007 was
approximately 600 persons and the Company anticipates total
headcount at March 31, 2008 to be approximately 440 persons, a
reduction of 160 personnel, including consultants, with a
further estimated reduction from anticipated attrition during
2008 of approximately 20 people, net, for a total reduction
from Sept. 30, 2007 of 180 persons.

- Reduction of approximately 45 jobs in North America and Canada and approximately 115 positions offshore, including
consultants, or 28% of its current workforce. Most of the
reductions are effective immediately, with a small number to
be completed prior to March 31, 2008. The Company will
recognize a charge in its financial statements for the first
quarter ending March 31, 2008 of approximately $2.0 million,
consisting of approximately $1.3 million in severance costs
and approximately $0.7 million in other costs including,
primarily, legal fees and future lease payments on its
Burlington, MA office, which it has completely
vacated. The estimated annual cost savings of these actions is
approximately $7.0 million.

- Additional terminations prior to today's rightsizing
announcement that have occurred since Sept. 30, 2007 aggregate approximately $3.0 million in annual cost savings.

- Based on the company's historical attrition run-rate, it
anticipates additional voluntary terminations during the
remainder of 2008 with annual cost savings of between $1.0 and $2.0 million.

- The aggregate estimated net reduction in the company's annual
recurring operating costs, including compensation, software
development and customer support costs, and office lease costs
is approximately $10.0 million per year plus an additional
$1.0 to $2.0 million of anticipated savings based on
historical attrition.

For more information: www.mergehealthcare.com

Related Content

iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
High-Strength MRI May Release Mercury from Amalgam Dental Fillings
News | Magnetic Resonance Imaging (MRI) | July 05, 2018
Exposure to ultra-high-strength magnetic resonance imaging (MRI) may release toxic mercury from amalgam fillings in...
Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning.

Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning. (Images courtesy of Metrasens)

Feature | Magnetic Resonance Imaging (MRI) | July 03, 2018 | By Tobias Gilk
Nearly every job in the country is subject to certain health and safety regulations. Construction workers must wear...
Technology | Magnetic Resonance Imaging (MRI) | June 27, 2018
June 27, 2018 — Zetta Medical Technologies announced the release of Zoom, its latest...
Children with Kidney Disease Show Blood Flow Changes in Brain
News | Neuro Imaging | June 25, 2018
Blood flow changes in the brains of children, adolescents and young adults with chronic kidney disease may explain why...
Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Reduced hippocampal volume on MRI

This figure shows reduced hippocampal volume over the course of 6 years as seen on progressive volumetric analysis and also coronal MRI evaluations (arrows).Progressive volume loss in the mesial temporal lobe on MRI is a characteristic imaging feature of AD. This patient was a case of Alzheimer’s Dementia.

 

News | Neuro Imaging | June 12, 2018
According to a UCLA Medical Center study, a new technology shows the potential to help doctors better determine when...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
Overlay Init